Welcome to the Future of Cancer Treatment
Join us for an Exclusive Presentation and Live Q&A Session
Thursday, November 7 at 12:00 pm EST
Phio Pharmaceuticals Corp., a cutting-edge clinical-stage biotechnology company, is revolutionizing the fight against cancer with its groundbreaking INTASYL® siRNA gene silencing technology. By enhancing the body’s immune cells to better target and destroy cancer cells, Phio Pharmaceuticals is paving the way towards a cancer-free future.
We are excited to announce that our CEO and Chairman of the Board, Mr. Robert Bitterman, will be presenting in the live Virtual Non-Deal Roadshow Series hosted by Renmark Financial Communications Inc. Mark your calendars for Thursday, November 7 at 12:00 pm EST to gain exclusive insights into the future of cancer treatment.
To register for this event and participate in the live Q&A session with Mr. Bitterman, please click here.
Don’t miss this opportunity to learn more about the latest advancements in cancer research and how Phio Pharmaceuticals is leading the charge in the fight against this devastating disease. Join us on November 7 to be a part of the future of cancer treatment.
How this will impact you:
By attending our presentation and live Q&A session, you will gain valuable knowledge about the latest developments in cancer treatment and how they could potentially benefit you or your loved ones in the future. Stay informed and be prepared to make informed decisions about your healthcare.
How this will impact the world:
The innovative technology being developed by Phio Pharmaceuticals has the potential to revolutionize cancer treatment on a global scale. By making the body’s immune cells more effective in fighting cancer cells, this technology could significantly improve survival rates and quality of life for cancer patients worldwide.
Conclusion:
Join us on November 7 to learn more about the future of cancer treatment and how Phio Pharmaceuticals is leading the way towards a cancer-free world. Together, we can make a difference in the fight against cancer and create a brighter future for all.
